Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.
Osenvelt, Stoboclo
Australian Public Assessment Report
Device/Product Name
Osenvelt, Stoboclo
Active ingredients
Denosumab
AusPAR Date
Published
Submission Number
PM-2024-00632-1-5
Submission Type
New biosimilar entity
Decision
Approved